/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. The BioHub - by Avetix
  2. Episode 224 - Wyatt McDonnell - CEO of Infinimmune
Episode 224 - Wyatt McDonnell - CEO of Infinimmune

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix · Sep 11, 2026

Infinimmune CEO Wyatt McDonnell on founding a therapeutics company from 10x Genomics, leveraging a human-centric platform for novel antibodies.

Infinimmune Chose a Therapeutics Focus, Believing Its Platform Created an Unbeatable Asset Moat

Despite having a powerful discovery platform, Infinimmune deliberately avoided becoming a service company. The founders believed their unique ability to connect human antibody biology directly to potential assets gave them a competitive advantage in drug development that few other companies could replicate, making therapeutics the highest-impact path.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

Infinimmune's CEO Credits Stubborn Conviction and Intense Curiosity as Essential Founder Traits

Wyatt McDonnell identifies stubbornness and a high degree of curiosity as critical for founders. He believes founders must hold strong convictions to push through adversity, yet remain curious and open enough to change their minds quickly in response to new evidence, striking a balance between unwavering belief and adaptability.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

Infinimmune's CEO Assembled His Founding Team Based on Workplace Reputation, Not Close Collaboration

Wyatt McDonnell recruited his entire founding team from his former employer, 10x Genomics. While they hadn't worked closely together, he targeted individuals who were highly respected for their specific contributions and ability to think robustly, prioritizing proven competence over prior direct working relationships.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

Recruiting Co-Founders Is the First and Most Critical Test of a CEO's Ability to Sell a Vision

Wyatt McDonnell argues that a CEO's success in convincing talented people to join a risky startup is a crucial early validation. This act of "selling the vision" to co-founders is the same skill required to recruit employees and persuade investors, making it a powerful signal of future success.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

Infinimmune's Rapid Platform Build Forced an Abrupt Shift from R&D to Corporate Strategy

The Infinimmune team built their core technology in six months, far ahead of their 18-24 month projection. This unexpected success created a "white space" that forced them to immediately grapple with later-stage challenges like target selection, market analysis, and partnership strategy, accelerating their evolution into a more mature company.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

A Diversified Investor Base Creates a More Robust Boardroom Dialogue

Infinimmune intentionally built a diverse investor base including tech-bio funds, traditional biotech VCs, and corporate venture arms like Merck and Regeneron. This diversity fosters a more "fulsome conversation" in the boardroom, allowing the company to analyze opportunities and challenges from multiple, complementary perspectives.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago

A Targeted Cold Outreach Strategy Landed Infinimmune's First VC Funding

Instead of relying on warm introductions, Wyatt McDonnell identified his ideal investors by researching who wrote the first checks into companies he admired. He then created a short list and conducted direct cold outreach, a strategy that quickly led to a match with their first investors.

Episode 224 - Wyatt McDonnell - CEO of Infinimmune thumbnail

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix·2 months ago